Patents by Inventor Masayuki KANKI

Masayuki KANKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT CELL (aAVC)
    Publication number: 20230381305
    Abstract: Provided is an effective and safe method for treating or preventing a cancer using aAVC. The present invention finds suitable ranges of the dose of ?-GalCer loaded on aAVC cell surface, and the amount of ?-GalCer loaded on aAVC cell surface in a pharmaceutical composition comprising aAVC, which are preferred in terms of securing effectiveness and safety in the treatment and prevention of a cancer using aAVC, and provides an effective and safe method for treating or preventing a cancer using aAVC, aAVC for effective and safe treatment or prevention of a cancer, and a pharmaceutical composition comprising the same, etc.
    Type: Application
    Filed: March 6, 2023
    Publication date: November 30, 2023
    Applicants: ASTELLAS PHARMA INC., RIKEN
    Inventors: Keisuke OHSUMI, Taku YOSHIDA, Masayuki KANKI, Shinichiro FUJII, Kanako SHIMIZU
  • Method for treating cancer using artificial adjuvant cell (aAVC)
    Patent number: 11617790
    Abstract: [Problem to be Solved] Provided is an effective and safe method for treating or preventing a cancer using aAVC. [Solution] The present invention finds suitable ranges of the dose of ?-GalCer loaded on aAVC cell surface, and the amount of ?-GalCer loaded on aAVC cell surface in a pharmaceutical composition comprising aAVC, which are preferred in terms of securing effectiveness and safety in the treatment and prevention of a cancer using aAVC, and provides an effective and safe method for treating or preventing a cancer using aAVC, aAVC for effective and safe treatment or prevention of a cancer, and a pharmaceutical composition comprising the same, etc.
    Type: Grant
    Filed: December 1, 2020
    Date of Patent: April 4, 2023
    Assignees: Astellas Pharma Inc., RIKEN
    Inventors: Keisuke Ohsumi, Taku Yoshida, Masayuki Kanki, Shinichiro Fujii, Kanako Shimizu
  • METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT CELL (aAVC)
    Publication number: 20220016239
    Abstract: [Problem to be Solved] Provided is an effective and safe method for treating or preventing a cancer using aAVC. [Solution] The present invention finds suitable ranges of the dose of ?-GalCer loaded on aAVC cell surface, and the amount of ?-GalCer loaded on aAVC cell surface in a pharmaceutical composition comprising aAVC, which are preferred in terms of securing effectiveness and safety in the treatment and prevention of a cancer using aAVC, and provides an effective and safe method for treating or preventing a cancer using aAVC, aAVC for effective and safe treatment or prevention of a cancer, and a pharmaceutical composition comprising the same, etc.
    Type: Application
    Filed: December 1, 2020
    Publication date: January 20, 2022
    Applicants: ASTELLAS PHARMA INC., RIKEN
    Inventors: Keisuke OHSUMI, Taku YOSHIDA, Masayuki KANKI, Shinichiro FUJII, Kanako SHIMIZU